Related Image: More People Living Longer After Cancer Diagnosis |
(Date:11/8/2009)...ADELPHIA, Nov. 8 The Am...he prevention and wellness provisions in the healt..., "With passage of this bill, the House takes impo...important insurance reforms and moving our health ...to one that focuses on keeping people healthy," sa...
(Date:11/8/2009)...er Costs and Crushing Taxes Nail Nation,s Job Crea...re/ -- In response to U.S. House passage of the he...ntrepreneurship Council (SBE Council) president &a...ent: ,, "Make no mistake, those voting for H.R...ith higher costs and crushing taxes and penalties....
(Date:11/8/2009)... Freeze-drying of biopharmaceutical...ga, Ontario facility. , ...lner, President and CEO of Therapure Biopharma Inc...ery of a commercial scale pharmaceutical grade fre...eze drying (lyophilization) available for contract...
(Date:11/8/2009)...ion,s largest network of Hispanic health advocates...orm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-...tatives showed they have heard the voice of Americ... for America Act. Now the Senate must deliver, wit...re reform," said Dr. Jane L. Delgado, President an...
(Date:11/8/2009)...P Praises House Passage of Health Care Reform Bill...icare, improve coverage for all Americans ,, C...he United States House of Representatives passed b...egislation that would strengthen Medicare for seni...that prices millions of Americans out of affordabl...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3(Date:11/6/2009)...-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nas...y, November 10, 2009 at 8:30 a.m. EST to discuss t...ss outlook for the remainder of 2009. Ron Bentsur...t the call. Keryx will announce its financial res...ed prior to the call. ,, In order to participat...
(Date:11/6/2009)...FirstCall/ -- Caraco Pharmaceutical Laboratories, ...methamine ophthalmic solution, 0.5% following a fi...ion (FDA) for Sun Pharma,s Abbreviated New Drug Ap...c solution on the first day following patent expir...ly equivalent to Acular® Ophthalmic Solution,...
(Date:11/5/2009)... 5 Transcept Pharmaceuti...tical company focused on the development and comme...important therapeutic needs in the field of neuros... teleconference with management to discuss third q...r 12, 2009, at 5:00 p.m. Eastern Standard Time. F...
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Gene findings revealing reasons for neuroblastoma risk 49275 1Gene findings revealing reasons for neuroblastoma risk 49275 2Study supports validity of test that indicates widespread unconscious bias 49273 1Study supports validity of test that indicates widespread unconscious bias 49273 2Roux en Y weight loss surgery raises kidney stone risk 49271 1Roux en Y weight loss surgery raises kidney stone risk 49271 2... and End-User Satisfaction, Enhanced Wor...Fla., Feb. 25 Today, at the,Healthcare Informatio...al,Conference and Exhibition in Orlando, Siemens, ...gent Health, the largest,not-for-profit, faith-bas...Iowa, announced the results of a clinician usabili...
... Co., Ltd.,announced today that its European licen... phase 2 proof of concept clinical study to invest...esterase type 5 inhibitor, for,portal hypertension...n,study is designed to investigate the safety and ...ents with portal hypertension resulting from liver...
Other Medicine Technology:Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 2Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 3Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 4Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing 5Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil 2Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil 3Troponin I - Rapid Test
...or many patients with a diseased heart, the only t...t transplant. However, donor organs are not always...le die while they are on the waiting list for a do... devices (VAD) can save the life of a patient. On ...
...nstaTest AFP is an immunochromatographic in vitro ...n human serum. AFP is a protein with molecular mas...entration in serum is below 9 ng/mL; higher concen... testicular and presacral teratocarcinomas, and ot...
Roche/STAGO STA Compact
Medicine Products: